---
figid: PMC5130074__PulmCirc-006-407.g001
figlink: /pmc/articles/PMC5130074/figure/fg1/
number: Figure 1
caption: 'Scheme depicting the possible mechanism of VEGFR-2-mediated vascular effects
  (cell proliferation, survival, migration, and enhanced permeability) related to
  vascular formation. VEGFR-2 is composed of an extracellular domain containing seven
  immunoglobulin-like domains, a transmembrane domain, and an intracellular domain
  of two kinase domains separated by a kinase-insert domain. The binding of the VEGF
  dimer to the receptor leads to the dimerization and autophosphorylation of specific
  intracellular tyrosine residues of the receptors. The phosphorylation of Y1175 recruits
  PLCγ, resulting in DAG release and activation of PKC and the Raf-MEK-ERK 1/2 signaling
  pathway and thus in stimulated cell proliferation. The phosphorylated Y1175 may
  also recruit adaptor protein Shb, which leads to activation of PI3K-PKB signaling;
  consequently, BAD and caspase are suppressed, which results in increased cell survival.
  Increased PI3K-PKB activity increases eNOS-dependent NO production, resulting in
  increased cell permeability, which facilitates angiogenesis through providing a
  proangiogenic extracellular environment. The phosphorylation of Y951 provides a
  binding site for TSAd, which causes the activation of Src, leading to increased
  cell migration and permeability. Increased cell migration also results from activation
  of Cdc42-p38 MAPK as a result of the phosphorylation of Y1214 and the formation
  of the Nck-Fyn complex. Solid arrows indicate activation and dashed arrows inhibition.
  BAD: B-cell lymphoma 2-associated death promoter; Cdc42: cell division cycle 42;
  DAG: diacylglycerol; eNOS: endothelial nitric oxide synthase; ERK 1/2: extracellular
  signal–regulated protein kinase 1 and 2; Fyn: proto-oncogene tyrosine-protein kinase
  Fyn; MEK: mitogen-activated protein kinase; Nck: Nck adaptor protein 1; NO, nitric
  oxide; p38 MAPK: p38 mitogen-activated protein kinase; PI3K: phosphatidylinositol-4,5-bisphosphate
  3-kinase; PKB: protein kinase B, also known as Akt; PKC: protein kinase C; PLCγ:
  phosphoinositide phospholipase C-γ; Raf: rapidly accelerated fibrosarcoma kinases;
  Shb: SH2-domain-containing adaptor protein B; Src: tyrosine-protein kinase CSK;
  TSAd: T cell-specific adaptor molecule; VEGF: vascular endothelial growth factor;
  VEGFR-2: VEGF receptor 2.'
pmcid: PMC5130074
papertitle: 'Unique aspects of the developing lung circulation: structural development
  and regulation of vasomotor tone.'
reftext: Yuangsheng Gao, et al. Pulm Circ. 2016 Dec;6(4):407-425.
pmc_ranked_result_index: '164544'
pathway_score: 0.9654809
filename: PulmCirc-006-407.g001.jpg
figtitle: Scheme depicting the possible mechanism of VEGFR-2-mediated vascular effects
  (cell proliferation, survival, migration, and enhanced permeability) related to
  vascular formation
year: '2016'
organisms: Homo sapiens
ndex: 4a706df0-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5130074__PulmCirc-006-407.g001.html
  '@type': Dataset
  description: 'Scheme depicting the possible mechanism of VEGFR-2-mediated vascular
    effects (cell proliferation, survival, migration, and enhanced permeability) related
    to vascular formation. VEGFR-2 is composed of an extracellular domain containing
    seven immunoglobulin-like domains, a transmembrane domain, and an intracellular
    domain of two kinase domains separated by a kinase-insert domain. The binding
    of the VEGF dimer to the receptor leads to the dimerization and autophosphorylation
    of specific intracellular tyrosine residues of the receptors. The phosphorylation
    of Y1175 recruits PLCγ, resulting in DAG release and activation of PKC and the
    Raf-MEK-ERK 1/2 signaling pathway and thus in stimulated cell proliferation. The
    phosphorylated Y1175 may also recruit adaptor protein Shb, which leads to activation
    of PI3K-PKB signaling; consequently, BAD and caspase are suppressed, which results
    in increased cell survival. Increased PI3K-PKB activity increases eNOS-dependent
    NO production, resulting in increased cell permeability, which facilitates angiogenesis
    through providing a proangiogenic extracellular environment. The phosphorylation
    of Y951 provides a binding site for TSAd, which causes the activation of Src,
    leading to increased cell migration and permeability. Increased cell migration
    also results from activation of Cdc42-p38 MAPK as a result of the phosphorylation
    of Y1214 and the formation of the Nck-Fyn complex. Solid arrows indicate activation
    and dashed arrows inhibition. BAD: B-cell lymphoma 2-associated death promoter;
    Cdc42: cell division cycle 42; DAG: diacylglycerol; eNOS: endothelial nitric oxide
    synthase; ERK 1/2: extracellular signal–regulated protein kinase 1 and 2; Fyn:
    proto-oncogene tyrosine-protein kinase Fyn; MEK: mitogen-activated protein kinase;
    Nck: Nck adaptor protein 1; NO, nitric oxide; p38 MAPK: p38 mitogen-activated
    protein kinase; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; PKB: protein
    kinase B, also known as Akt; PKC: protein kinase C; PLCγ: phosphoinositide phospholipase
    C-γ; Raf: rapidly accelerated fibrosarcoma kinases; Shb: SH2-domain-containing
    adaptor protein B; Src: tyrosine-protein kinase CSK; TSAd: T cell-specific adaptor
    molecule; VEGF: vascular endothelial growth factor; VEGFR-2: VEGF receptor 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SH2D2A
  - VEGFD
  - ARAF
  - RAF1
  - PIK3CB
  - PLCZ1
  - PGF
  - VEGFA
  - BRAF
  - SHB
  - MAPK10
  - MAPK13
  - MAPK12
  - PLCD4
  - MAP2K2
  - SRC
  - MAPK1
  - MAP2K1
  - PIK3CA
  - BAD
  - PIK3CD
  - PIK3R5
  - PIK3R3
  - AKT1
  - PLCD3
  - PIK3CG
  - MAPK3
  - VEGFB
  - PLCB4
  - PLCB1
  - PLCG1
  - PLCG2
  - NOS3
  - FYN
  - MAPK14
  - MAPK11
  - VEGFC
  - KDR
  - MAPK8
  - MAPK9
  - CASP12
  - CASP14
  - CASP1
  - CASP2
  - NCK1
  - CASP4
  - PLCE1
  - PLCB2
  - PIK3R4
  - PIK3R6
  - CASP9
  - CASP10
  - CDC42
  - PLCD1
  - CASP8
  - CASP5
  - CASP3
  - CASP6
  - CASP7
  - PLCB3
  - Cancer
genes:
- word: TSAD
  symbol: TSAd
  source: hgnc_alias_symbol
  hgnc_symbol: SH2D2A
  entrez: '9047'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Shb
  symbol: SHB
  source: hgnc_symbol
  hgnc_symbol: SHB
  entrez: '6461'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Fyn
  symbol: FYN
  source: hgnc_symbol
  hgnc_symbol: FYN
  entrez: '2534'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGFR-2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Nck
  symbol: NCK
  source: hgnc_prev_symbol
  hgnc_symbol: NCK1
  entrez: '4690'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Cdc42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
